EWTX position history
The shares of Edgewise Therapeutics (EWTX) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q1: 356,750 shares, $3.5M, 0.90% of portfolio, New
- 2022 Q2: 695,959 shares, $5.5M, 1.5% of portfolio, Add +95.1%
- 2022 Q3: 781,112 shares, $7.7M, 2.1% of portfolio, Add +12.2%
- 2022 Q4: 766,843 shares, $6.9M, 1.9% of portfolio, Reduce −1.8%
- 2023 Q1: 733,239 shares, $4.9M, 1.5% of portfolio, Reduce −4.4%
- 2023 Q2: 519,384 shares, $4M, 1.1% of portfolio, Reduce −29.2%
- 2023 Q3: 519,384 shares, $3M, 0.93% of portfolio
- 2023 Q4: 449,384 shares, $4.9M, 1.2% of portfolio, Reduce −13.5%
- 2024 Q1: 306,197 shares, $5.6M, 1.3% of portfolio, Reduce −31.9%
- 2024 Q2: 290,197 shares, $5.2M, 1.2% of portfolio, Reduce −5.2%
- 2024 Q3: 227,906 shares, $6.1M, 1.4% of portfolio, Reduce −21.5%
- 2024 Q4: 187,140 shares, $5M, 1.3% of portfolio, Reduce −17.9%
- 2025 Q1: 183,140 shares, $4M, 1.1% of portfolio, Reduce −2.1%
- 2025 Q2: 238,140 shares, $3.1M, 0.86% of portfolio, Add +30.0%
- 2025 Q3: 213,736 shares, $3.5M, 0.86% of portfolio, Reduce −10.2%
- 2025 Q4: 159,736 shares, $4M, 0.92% of portfolio, Reduce −25.3%
- 2026 Q1: 112,236 shares, $3.5M, 0.80% of portfolio, Reduce −29.7%
- 2026 Q2: 226,819 shares, $9.2M, 1.8% of portfolio, Add +102.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|